ROCK SPRINGS CAPITAL
Rock Springs Capital is an investment company located in Baltimore, Maryland. Its advisory activities include management services to security portfolios and portfolio management for businesses or institutional clients.
ROCK SPRINGS CAPITAL
Industry:
Financial Services Venture Capital
Founded:
2013-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apache Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Lux Capital
Lux Capital is an investment firm investing in counter-conventional, early-stage science, and tech ventures.
Zeev Ventures
Zeev Ventures is an early-stage venture fund that invests in technology, financial, e-commerce, and consumer service sectors.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-19 | Kymera Therapeutics | Rock Springs Capital investment in Post-IPO Equity - Kymera Therapeutics | 150 M USD |
| 2022-08-10 | Disc Medicine | Rock Springs Capital investment in Venture Round - Disc Medicine | N/A |
| 2022-07-18 | Delfi Diagnostics | Rock Springs Capital investment in Series B - Delfi Diagnostics | 225 M USD |
| 2022-07-18 | Immunocore | Rock Springs Capital investment in Post-IPO Equity - Immunocore | 140 M USD |
| 2022-07-13 | Gossamer Bio | Rock Springs Capital investment in Post-IPO Equity - Gossamer Bio | 120 M USD |
| 2022-06-08 | Mineralys Therapeutics | Rock Springs Capital investment in Series B - Mineralys Therapeutics | 118 M USD |
| 2022-05-10 | MOMA Therapeutics | Rock Springs Capital investment in Series B - MOMA Therapeutics | 150 M USD |
| 2022-02-22 | MiRXES | Rock Springs Capital investment in Series C - MiRXES | 87 M USD |
| 2022-01-27 | Simcha Therapeutics | Rock Springs Capital investment in Series B - Simcha Therapeutics | 40 M USD |
| 2022-01-05 | AvengeBio | Rock Springs Capital investment in Series A - AvengeBio | 45 M USD |